Pay in 4 interest-free payments of $7.39 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
That number comes from the Phase 3 TRIUMPH-4 trial, which ran from enrollment through a full 68-week treatment period with participants receiving either 9 mg or 12 mg weekly injections
Its not for those who havent tried lifestyle changes or who have certain health conditions
Consult your healthcare provider : Discuss your reasons for discontinuation and whether it is truly necessary
High GHRH-R Selectivity No GHS-R1a Cross-Reactivity Modified GRF (1-29) demonstrates high selectivity for GHRHR, with minimal cross-reactivity to other pituitary hormone receptors including the growth hormone secretagogue receptor (GHS-R1a) that mediates the effects of ghrelin and GHRPs such as Ipamorelin
US$ 24.22
US$ 24.22
US$ 29.54
US$ 24.32
US$ 23.17
